Tummy bug testing outfit Genetic Signatures is honing its operations after finding its company-making US expansion was harder than expected.

Fifth Third has made some changes to its C-suite as one leader retires.

CNBC's Steve Kovach joins 'Closing Bell Overtime' to talk the latest C-Suite changes coming to Apple.

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases ...

CEO and C-suite perceptions of AI risk do not always align PM Modi invited for state dinner, Xi Jinping pulls out of BRICS Summit for the first time in 12 years Mohd Rafi was depressed, grew his ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on June 30, 2025 that were previo ...

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) Jun. 30, 2025 6:26 PM ET Sarepta Therapeutics, Inc. (SRPT) ...

SRPT INVESTOR NOTICE: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit ...

Analytics and data transformation platform developer Alteryx has hired former Bluecore and Salesforce executive Arvind Krishnan as the company’s new chief technology officer.

LOS ANGELES, June 26, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Sarepta Therapeutics, Inc. ("Sarepta Therapeutics" or the "Company") (NASDAQ; SRPT) investors of a class action ...

NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Sarepta ...